» Articles » PMID: 33953628

Portable Diagnostic System for Age-Related Macular Degeneration Screening Using Visual Evoked Potentials

Overview
Journal Eye Brain
Publisher Dove Medical Press
Date 2021 May 6
PMID 33953628
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Delayed Dark-Adapted vision Recovery (DAR) is a biomarker for Age-related Macular Degeneration (AMD), however its measurement is burdensome for patients and examiners.

Methods: In this study, we developed a portable, wireless and user-friendly system that employs a headset with a smartphone to deliver controlled photo-bleach and monocular pattern reversal stimuli, while using custom electroencephalography (EEG) electrodes and electronics in order to measure Dark-Adapted Visual Evoked Potentials (DAVEP) objectively and separately at the peripheral and central visual field. This is achieved in one comfortable 20-minute session, without requiring subject reporting. DAVEP responses post photo-bleach for up to 15 minutes were measured concurrently from both eyes in 12 AMD-patients, 1 degenerative myopia patient, and 8 controls who had no diagnosed macular vision loss.

Results: Robust positive polarity DAVEP responses were observed at 200-500 ms from stimulus onset to scotopic stimuli that have been seldom reported and analyzed previously. The amplitude recovery of the DAVEP response was significantly delayed in AMD patients as compared to controls. We developed DAVEP1 scores, a simple metric for DAR, which classified 90% of subject eyes correctly, indicating the presence of AMD in at least one eye of all pre-confirmed subjects with this diagnosis.

Conclusion: We developed a user-friendly, portable VEP system and DAVEP1 metric, which show a high potential to identify DAR-deficits in AMD-patients. This novel technology could aid in early diagnosis of AMD.

Citing Articles

Portable multi-focal visual evoked potential diagnostics for multiple sclerosis/optic neuritis patients.

Banijamali S, Versek C, Babinski K, Kamarthi S, Green-LaRoche D, Sridhar S Doc Ophthalmol. 2024; 149(1):23-45.

PMID: 38955958 PMC: 11236877. DOI: 10.1007/s10633-024-09980-z.


Psychophysical, electrofunctional, and morphological evaluation in naïve neovascular AMD patients treated with intravitreal anti-VEGF.

Nebbioso M, Franzone F, Milanese A, Artico M, Taurone S, La Cava M Aging Med (Milton). 2024; 7(2):189-201.

PMID: 38725692 PMC: 11077329. DOI: 10.1002/agm2.12296.


Portable Multi-focal Visual Evoked Potential Diagnostics for Multiple Sclerosis/Optic Neuritis patients.

Banijamali S, Versek C, Babinski K, Kamarthi S, Green-LaRoche D, Sridhar S medRxiv. 2024; .

PMID: 38234795 PMC: 10793525. DOI: 10.1101/2023.12.26.23300405.


Visual Evoked Potentials for the Detection of Diabetic Retinal Neuropathy.

Miura G Int J Mol Sci. 2023; 24(8).

PMID: 37108524 PMC: 10138821. DOI: 10.3390/ijms24087361.


Human retinal dark adaptation tracked in vivo with the electroretinogram: insights into processes underlying recovery of cone- and rod-mediated vision.

Jiang X, Mahroo O J Physiol. 2022; 600(21):4603-4621.

PMID: 35612091 PMC: 9796346. DOI: 10.1113/JP283105.

References
1.
Legge G, Rubin G, Pelli D, Schleske M . Psychophysics of reading--II. Low vision. Vision Res. 1985; 25(2):253-65. DOI: 10.1016/0042-6989(85)90118-x. View

2.
Polich J . Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol. 2007; 118(10):2128-48. PMC: 2715154. DOI: 10.1016/j.clinph.2007.04.019. View

3.
Airas K, Petersen J . Objective determination of dark adaptation: accuracy of the evoked potential method. Graefes Arch Clin Exp Ophthalmol. 1985; 223(2):63-5. DOI: 10.1007/BF02150946. View

4.
Owsley C, Jackson G, White M, Feist R, Edwards D . Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001; 108(7):1196-202. DOI: 10.1016/s0161-6420(01)00580-2. View

5.
Alten F, Heiduschka P, Clemens C, Eter N . Multifocal electroretinography in eyes with reticular pseudodrusen. Invest Ophthalmol Vis Sci. 2012; 53(10):6263-70. DOI: 10.1167/iovs.12-10094. View